Advertisement
Mayo Clinic Proceedings Home

Management of Mild Hypertension

      The benefits of blood pressure reduction have been clearly established for diastolic pressures of more than 100 mm Hg. For patients with a diastolic pressure between 90 and 99 mm Hg on repeated measurements, treatment should be initiated if other risk factors are present—for example, a family history of coronary risk, increased cholesterol level, male sex, smoking, or diabetes mellitus. When the pressure seems to be labile or exaggerated in the office, home or ambulatory readings may provide confirmatory information. For persons with diastolic pressures in the range of 90 to 94 mm Hg, it may be suitable to initiate therapy with nonpharmacologic maneuvers such as sodium restriction, weight reduction, and physical conditioning. In such cases, careful follow-up of blood pressure is particularly important because it may increase later. The initial therapy for mild hypertension should be selected to minimize adverse effects and should be tailored to the individual patient. Management of all levels of hypertension must be considered in light of the associated risk factors and a concomitant effort to minimize cardiovascular risk.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • The Pooling Project Research Group
        Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project.
        J Chronic Dis. 1978; 31: 201-306
        • Applegate WB
        Hypertension in elderly patients.
        Ann Intern Med. 1989; 110: 901-915
        • Veterans Administration Cooperative Study Group on Antihypertensive Agents
        Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.
        JAMA. 1970; 213: 1143-1152
        • Julius S
        • Pascual AV
        • Sannerstedt R
        • Mitchell C
        Relationship between cardiac output and peripheral resistance in borderline hypertension.
        Circulation. 1971; 43: 382-390
        • Messerli FH
        • De Carvalho JGR
        • Christie B
        • Frohlich ED
        Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension.
        Circulation. 1978; 58: 441-448
        • Messerli FH
        • Frohlich ED
        • Suarez DH
        • Reisin E
        • Dreslinski GR
        • Dunn FG
        • Cole FE
        Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines.
        Circulation. 1981; 64: 760-764
        • Zachariah PK
        • Sheps SG
        • Ilstrup DM
        • Long CR
        • Bailey KR
        • Wiltgen CM
        • Carlson CA
        Blood pressure load—a better determinant of hypertension.
        Mayo Clin Proc. 1988; 63: 1085-1091
        • MacMahon SW
        • Cutler JA
        • Furberg CD
        • Payne GH
        The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials.
        Prog Cardiovasc Dis. 1986; 29: 99-118
        • Ibrahim MM
        • Tarazi RC
        • Dustan HP
        • Gifford Jr, RW
        Electrocardiogram in evaluation of resistance to antihypertensive therapy.
        Arch Intern Med. 1977; 137: 1125-1129
        • Perloff D
        • Sokolow M
        • Cowan R
        The prognostic value of ambulatory blood pressures.
        JAMA. 1983; 249: 2792-2798
        • Multiple Risk Factor Intervention Trial Research Group
        Multiple Risk Factor Intervention Trial: risk factor changes and mortality results.
        JAMA. 1982; 248: 1465-1477
        • Smith WM
        Treatment of mild hypertension: results of a ten-year intervention trial.
        Circ Res. 1977; 40: I98-I105
        • Helgeland A
        Treatment of mild hypertension: a five year controlled drug trial; the Oslo study.
        Am J Med. 1980; 69: 725-732
      1. The Australian Therapeutic Trial in Mild Hypertension: report by the management committee.
        Lancet. 1980; 1: 1261-1267
        • Hypertension Detection and Follow-Up Program Cooperative Group
        The effect of treatment on mortality in “mild” hypertension.
        N Engl J Med. 1982; 307: 976-980
        • Medical Research Council Working Party
        MRC trial of treatment of mild hypertension: principal results.
        Br Med J. 1985; 291: 97-104
        • Amery A
        • Birkenhäger W
        • Brixko P
        • Bulpitt C
        • Clement D
        • Deruyttere M
        • De Schaepdryver A
        • Dollery C
        • Fagard R
        • Forette F
        • Forte J
        • Hamdy R
        • Henry JF
        • Joossens JV
        • Leonetti G
        • Lund-Johansen P
        • O'Malley K
        • Petrie J
        • Strasser T
        • Tuomilehto J
        • Williams B
        Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.
        Lancet. 1985; 1: 1349-1354
        • Multiple Risk Factor Intervention Trial Research Group
        Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial.
        Am J Cardiol. 1985; 55: 1-15
        • Grimm Jr, RH
        • Leon AS
        • Hunninghake DB
        • Lenz K
        • Hannan P
        • Blackburn H
        Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial.
        Ann Intern Med. 1981; 94: 7-11
        • O'Kelly BF
        • Massie BM
        • Tubau JF
        • Szlachcic J
        Coronary morbidity and mortality, pre-existing silent coronary artery disease, and mild hypertension.
        Ann Intern Med. 1989; 110: 1017-1026
        • Levy D
        • Anderson KM
        • Savage DD
        • Kannel WB
        • Christiansen JC
        • Castelli WP
        Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors; the Framingham heart study.
        Ann Intern Med. 1988; 108: 7-13
        • Goldman L
        • Cook EF
        The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle.
        Ann Intern Med. 1984; 101: 825-836
        • Lipid Research Clinics Program
        The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
        JAMA. 1984; 251: 351-364
        • Anderson KM
        • Castelli WP
        • Levy D
        Cholesterol and mortality: 30 years of follow-up from the Framingham study.
        JAMA. 1987; 257: 2176-2180
        • Weidmann P
        • Gerber A
        • Mordasini R
        Effects of antihypertensive therapy on serum lipoproteins.
        Hypertension. 1983; 5: 120-131
        • Wilhelmsen L
        • Berglund G
        • Elmfeldt D
        • Fitzsimons T
        • Holzgreve H
        • Hosie J
        • Hörnkvist P-E
        • Pennert K
        • Tuomilehto J
        • Wedel H
        Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.
        J Hypertens. 1987; 5: 561-572
        • Haynes RB
        • Sackett DL
        • Taylor DW
        • Gibson ES
        • Johnson AL
        Increased absenteeism from work after detection and labeling of hypertensive patients.
        N Engl J Med. 1978; 299: 741-744
        • Cruickshank JM
        • Thorp JM
        • Zacharias FJ
        Benefits and potential harm of lowering high blood pressure.
        Lancet. 1987; 1: 581-584
        • Abernethy JD
        The need to treat mild hypertension: misinterpretation of results from the Australian trial.
        JAMA. 1986; 256: 3134-3137